Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking […]
